A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Phase 2, Multi-Center, Dose-Finding Study to Evaluate the Effects of RAD1901 in the Treatment of Vasomotor Symptoms in Postmenopausal Women.

Trial Profile

A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Phase 2, Multi-Center, Dose-Finding Study to Evaluate the Effects of RAD1901 in the Treatment of Vasomotor Symptoms in Postmenopausal Women.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Feb 2017

At a glance

  • Drugs Elacestrant (Primary)
  • Indications Hot flashes
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Radius Health Inc.
  • Most Recent Events

    • 23 Feb 2017 The company expects to report results from this trial in the first half of 2017, according to a Radius Health media release.
    • 22 Jun 2010 Results presented at the 92nd Annual Meeting of the Endocrine Society
    • 19 Jun 2010 Results reported in a Radius media release. Results will be presented at ENDO in June 2010.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top